Dublin, Jan. 31, 2022 (GLOBE NEWSWIRE) -- The "Urinary Incontinence Market by Product, Incontinence Type, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.
The global urinary incontinence market was valued at $10,124.33 million in 2020, and is projected to reach $19,341.15 million by 2030, registering a CAGR of 6.8% from 2021 to 2030.
The involuntary flow of urine due to a loss of bladder control is known as urinary incontinence. Urinary incontinence devices aid in collecting and holding urine; such devices help in managing urinary incontinence effectively. People undergoing urinary incontinence suffer from urine leakage that cannot be controlled. Patients suffering from severe urinary incontinence are recommended surgical treatment that incorporates devices such as urinary catheter, vaginal slings, electrical stimulation devices, and artificial urinary sphincters.
Among the aforementioned incontinent devices, the most evidently used devices include indwelling catheters, external collecting systems, urine drainage bags, and catheters for intermittent catheterization (IC). In incontinence, there is involuntary or accidental release of the contents from the urinary bladder, known as urinary incontinence or over rectal muscle (bowel or flatulence) known as rectal incontinence. Incontinence is a widespread condition that ranges in severity from just a small leak to complete loss of bladder or bowel control.
Disposable incontinence products are primarily used by the people suffering from urinary incontinence. These are mostly used by the elderly population, who are unable to control the urinary influx. The disposable incontinence products are preferably made up of medical grade nonwoven fabrics. Medical nonwovens are a distinctive class of textile materials designed from fibers that are bonded together to form a lucid structure. Medical nonwovens are either made up of natural fiber-like cotton, linen, or of synthetic materials such as polypropylene, polyester, polytetrafluoroethylene (PTFE), and others. Medical nonwoven disposable incontinence products are commonly used in surgical processes, serving as a barrier to microorganisms, and prevent infections.
Development of innovative urinary incontinence devices and rise in demand for minimally invasive surgeries along with increase in aging population that is highly susceptible to urological conditions drive the growth of the urinary incontinence devices market. In addition, the increase in the urinary incontinent patients transitioning from conventional solutions is set to increase in near future. Further, high risk of associative urological conditions among people supplements the growth of the market. However, lack of awareness regarding novel developments in the urinary incontinence devices and post-operative complications associated with the devices hamper the market growth. Moreover, the growth in healthcare expenditures in the developing economies is anticipated to create numerous opportunities for key vendors in this market.
The urinary incontinence market is segmented on the basis of product, incontinence type, end user, and region. By product, the market is divided into devices and disposables. The devices segment is further bifurcated into urinary catheters, vaginal slings, Electrical stimulation devices, artificial urinary sphincters, other devices and category. Urinary catheters are sub segmented into Foley catheters and other urinary catheters. Vaginal slings segment is sub segmented into conventional vaginal slings and advanced vaginal slings. On the basis of category, it is classified into external urinary incontinence devices and internal urinary incontinence devices. The disposables segment is further divided into disposable underwear, disposable shields, disposable diapers, disposable underpads, and others. By incontinence type, the market is categorized into stress urinary incontinence, urge urinary incontinence, overflow urinary incontinence, and functional urinary incontinence. Further, by end user, it is classified into hospitals and clinics, homecare, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include Becton, Dickinson and Company (C.R. Bard Inc.), Boston Scientific Corporation, Caldera Medical, Coloplast A/S, ConvaTec Group plc, Cook Group Inc., Johnson and Johnson, Laborie Medical, Medtronic Plc., Teleflex Incorporated, Ahlstrom-Munksjo, Asahi Kasei Corporation, Berry Global Inc., Cardinal Health, Inc., Domtar Corporation, First Quality Enterprises, Inc., Freudenberg and Co. KG, Georgia-Pacific LLC, Kimberly-Clark Corporation, and Unicharm Corporation.
Key Benefits
- The study provides an in-depth analysis of the global urinary incontinence market along with the current trends and future estimations to explain the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the key segments of the industry helps to understand the application and products of urinary incontinence device used across the globe.
- Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
Key Topics Covered:
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter's Five Forces analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Development of innovative urinary incontinence devices & rising
demand for minimally invasive procedures
3.5.1.2. Increase in aging population coupled with high risk of urological
disorders
3.5.1.3. Rise in shift from conventional solutions to novel urinary incontinent products
3.5.1.4. Growth in elderly population
3.5.1.5. Efficiency in the prevention of hospital-acquired infections (HAIs)
3.5.2. Restraints
3.5.2.1. Lack of awareness regarding novel developments in the urinary incontinence devices coupled with underreported cases of urinary incontinence
3.5.2.2. Post-operative complications associated with the devices
3.5.2.3. Rise in concerns toward disposal products
3.5.3. Opportunities
3.5.3.1. Growth in healthcare expenditures in the developing economies
3.5.3.2. Rise in technology integration
3.5.4. Impact analysis
3.6. COVID-19 Impact analysis on urinary incontinence market
CHAPTER 4: URINARY INCONTINENCE MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Devices
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market size and forecast, by devices
4.2.4. Market share analysis, by country
4.2.5. Urinary catheters
4.2.5.1. Key trends and opportunities
4.2.5.2. Market size and forecast
4.2.5.3. Foley catheters
4.2.5.4. Other urinary catheters
4.2.6. Vaginal slings
4.2.6.1. Key trends and opportunities
4.2.6.2. Market size and forecast
4.2.6.3. Conventional vaginal slings
4.2.6.4. Advanced vaginal slings
4.2.7. Electrical stimulation devices
4.2.7.1. Key trends and opportunities
4.2.8. Artificial urinary sphincters
4.2.8.1. Key trends and opportunities
4.2.9. Other devices
4.2.9.1. Key trends and opportunities
4.2.10. Urinary incontinence devices market size and forecast, by category
4.2.10.1. Market size and forecast
4.2.10.2. External urinary incontinence devices
4.2.10.3. Internal urinary incontinence devices
4.3. Disposables
4.3.1. Market size and forecast
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis, by country
4.3.4. Disposable underwear
4.3.4.1. Key market trends and opportunities
4.3.5. Disposable shields
4.3.5.1. Key market trends and growth opportunities
4.3.6. Disposable diapers
4.3.6.1. Key market trends and opportunities
4.3.7. Disposable underpads
4.3.7.1. Key market trends and opportunities
4.3.8. Others
4.3.8.1. Key market trends and opportunities
CHAPTER 5: URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Stress urinary incontinence
5.2.1. Market size and forecast by region.
5.2.2. Market analysis, by country
5.3. Urge urinary incontinence
5.3.1. Market size and forecast by region.
5.3.2. Market analysis, by country
5.4. Overflow urinary incontinence
5.4.1. Market size and forecast by region
5.4.2. Market analysis, by country
5.5. Functional urinary incontinence
5.5.1. Market size and forecast by region
5.5.2. Market analysis, by country
CHAPTER 6: URINARY INCONTINENCE MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals and Clinics
6.2.1. Market size and forecast by region.
6.2.2. Market analysis, by country
6.3. Home Care
6.3.1. Market size and forecast by region
6.3.2. Market share analysis, by country
6.4. Others
6.4.1. Market size and forecast by region.
6.4.2. Market share analysis, by country
CHAPTER 7: URINARY INCONTINENCE MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by product
7.2.3. Market size and forecast, by incontinence type
7.2.4. Market size and forecast, by end user
7.2.5. Market size & forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by product
7.2.5.1.2. Market size and forecast, by incontinence type
7.2.5.1.3. Market size and forecast by end user
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by product
7.2.5.2.2. Market size and forecast by incontinence type
7.2.5.2.3. Market size and forecast, by end user
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast by product
7.2.5.3.2. Market size and forecast, by incontinence type
7.2.5.3.3. Market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by product
7.3.3. Market size and forecast, by incontinence type
7.3.4. Market size and forecast, by end user
7.3.5. Europe market size & forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by product
7.3.5.1.2. Market size and forecast, by incontinence type
7.3.5.1.3. Market size and forecast by end user
7.3.5.2. France
7.3.5.2.1. Market size and forecast by product
7.3.5.2.2. Market size and forecast by incontinence type
7.3.5.2.3. Market size and forecast by end user
7.3.5.3. UK
7.3.5.3.1. Market size and forecast by product
7.3.5.3.2. Market size and forecast by incontinence type
7.3.5.3.3. Market size and forecast by end user
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast by product
7.3.5.4.2. Market size and forecast by incontinence type
7.3.5.4.3. Market size and forecast by end user
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast by product
7.3.5.5.2. Market size and forecast by incontinence type
7.3.5.5.3. Market size and forecast by end user
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast by product
7.3.5.6.2. Market size and forecast by incontinence type
7.3.5.6.3. Market size and forecast by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by product
7.4.3. Market size and forecast, by incontinence type
7.4.4. Market size and forecast, by end user
7.4.5. Asia-Pacific market size & forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by product
7.4.5.1.2. Market size and forecast, by incontinence type
7.4.5.1.3. Market size and forecast by end user
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by product
7.4.5.2.2. Market size and forecast, by incontinence type
7.4.5.2.3. Market size and forecast by end user
7.4.5.3. Australia
7.4.5.3.1. Market size and forecast, by product
7.4.5.3.2. Market size and forecast, by incontinence type
7.4.5.3.3. Market size and forecast by end user
7.4.5.4. India
7.4.5.4.1. Market size and forecast, by product
7.4.5.4.2. Market size and forecast, by incontinence type
7.4.5.4.3. Market size and forecast by end user
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by product
7.4.5.5.2. Market size and forecast, by incontinence type
7.4.5.5.3. Market size and forecast by end user
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by product
7.4.5.6.2. Market size and forecast, by incontinence type
7.4.5.6.3. Market size and forecast by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by product
7.5.3. Market size and forecast, by incontinence type
7.5.4. Market size and forecast, by end user
7.5.5. LAMEA market size & forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by product
7.5.5.1.2. Market size and forecast, by incontinence type
7.5.5.1.3. Market size and forecast by end user
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by product
7.5.5.2.2. Market size and forecast, by incontinence type
7.5.5.2.3. Market size and forecast by end user
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by product
7.5.5.3.2. Market size and forecast, by incontinence type
7.5.5.3.3. Market size and forecast by end user
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by product
7.5.5.4.2. Market size and forecast, by incontinence type
7.5.5.4.3. Market size and forecast by end user
CHAPTER 8: COMPANY PROFILES
8.1. BECTON, DICKINSON AND COMPANY (C.R. BARD INC.)
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.2. BOSTON SCIENTIFIC CORPORATION
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. CALDERA MEDICAL
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.4. COLOPLAST A/S
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. CONVATEC GROUP PLC
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. COOK GROUP INC. (COOK MEDICAL INC.)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.7. JOHNSON & JOHNSON (ETHICON INC.)
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. LABORIE MEDICAL (COGENTIX MEDICAL INC.)
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.9. MEDTRONIC PLC
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. TELEFLEX INCORPORATED
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.11. AHLSTROM-MUNKSJO
8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Operating business segments
8.11.4. Product portfolio
8.11.5. Business performance
8.11.6. Key strategic moves and developments
8.12. ASAHI KASEI CORPORATION
8.12.1. Company overview
8.12.2. Company snapshot
8.12.3. Operating business segments
8.12.4. Product portfolio
8.12.5. Business performance
8.12.6. Key strategic moves and developments
8.13. BERRY GLOBAL INC.
8.13.1. Company overview
8.13.2. Company snapshot
8.13.3. Operating business segments
8.13.4. Product portfolio
8.13.5. Business performance
8.14. CARDINAL HEALTH, INC.
8.14.1. Company overview
8.14.2. Company snapshot
8.14.3. Operating business segments
8.14.4. Product portfolio
8.14.5. Business performance
8.15. DOMTAR CORPORATION
8.15.1. Company overview
8.15.2. Operating business segments
8.15.3. Product portfolio
8.15.4. Business performance
8.15.5. Key strategic moves and developments
8.16. FIRST QUALITY ENTERPRISES, INC.
8.16.1. Company overview
8.16.2. Company snapshot
8.16.3. Operating business segments
8.16.4. Product portfolio
8.16.5. Key strategic moves and developments
8.17. FREUDENBERG & CO. KG
8.17.1. Company overview
8.17.2. Company snapshot
8.17.3. Operating business segments
8.17.4. Product portfolio
8.18. GEORGIA-PACIFIC LLC
8.18.1. Company overview
8.18.2. Company snapshot
8.18.3. Operating business segments
8.18.4. Product portfolio
8.19. KIMBERLY-CLARK CORPORATION
8.19.1. Company overview
8.19.2. Company snapshot
8.19.3. Operating business segment
8.19.4. Product portfolio
8.19.5. Business performance
8.20. UNICHARM CORPORATION
8.20.1. Company Overview
8.20.2. Company snapshot
8.20.3. Operating business segments
8.20.4. Product portfolio
8.20.5. Business performance
For more information about this report visit https://www.researchandmarkets.com/r/i9cj7y
